Related Experiment Video
Updated: Oct 2, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic
Frédéric Féger1, Antoine Ribadeau Dumas, Laurence Leriche
1Cellular and Molecular Hematology Unit, Faculty of Pharmacy, Paris, France.
Abstract:
Mastocytosis is a heterogeneous group of hematopoietic disorders characterized by abnormal growth and accumulation of mast cells (MC) in one or more organs. Clinical symptoms occur as a result of the release of chemical mediators and/or of pathologic infiltration of MC in various tissues. Although the initial events leading to mastocytosis have not yet been unraveled, acquired alterations in the c-kit gene coding for the receptor of stem cell factor (SCF), a major cytokine involved in MC growth, have been described in a significant number of patients. Of particular interest are point mutations resulting in a constitutively activated SCF receptor. Such mutations are probably involved in the abnormal (SCF-independent) proliferation of MC in these patients. New therapeutic strategies may be envisaged to inhibit the deregulated kinase activity of these mutant forms of c-kit.
More Related Videos
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Karyotyping
Receptor Tyrosine Kinases
PI3K/mTOR/AKT Signaling Pathway

